However, we have not observed significant correlation between SPRY4-IT1 expression levels and other clinical characteristics such as age, gender, serum AFP level, HBsAg status, tumor size, liver cirrhosis and histological differentiation (Table 1). This evidence concerns the gene HAUS3 and cirrhosis of liver.